← Evidence map

ReviewCancer chemotherapy and pharmacology2026

Antibody-drug conjugates in lung cancer: clinical development, therapeutic advances, and emerging challenges.

Yilin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42862216